Oral sirolimus to prevent restenosis after stenting de novo coronary lesions

被引：0
|
作者：
Costantini, CR [1 ]
Zanuttini, D [1 ]
Tarbine, S [1 ]
Darwich, R [1 ]
Lazarte, JL [1 ]
Costantini, CO [1 ]
Maranhao, M [1 ]
Andrade, M [1 ]
Oliveira, MR [1 ]
Sabattini, L [1 ]
Yared, G [1 ]
Bubna, M [1 ]
Medeiro, M [1 ]
Rubbini, L [1 ]
Freitas, M [1 ]
机构：
[1] Clin Cardiol C Costantini, Curitiba, Parana, Brazil
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2003年 / 41卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：24A / 25A
页数：2
相关论文
共 50 条
  • [1] Oral rapamycin to inhibit restenosis after stenting of de novo coronary lesions - The Oral Rapamune to Inhibit Restenosis (ORBIT) Study
    Waksman, R
    Ajani, AE
    Pichard, AD
    Torguson, R
    Pinnow, E
    Carlos, D
    Satler, LF
    Kent, KM
    Kuchulakanti, P
    Pappas, C
    Gambone, L
    Weissman, N
    Abbott, MC
    Lindsay, J
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 44 (07) : 1386 - 1392
  • [2] Oral Rapamune to inhibit restenosis in patients with multi de novo coronary lesions requiring stenting
    Waksman, R
    Pichard, AD
    Ajani, AE
    Torguson, R
    Pinnow, E
    Gambone, L
    Gevorkian, N
    Abbott, MC
    Satler, LF
    Kent, KM
    Lindsay, J
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 51A - 51A
  • [3] Oral rapamycin to inhibit restenosis in de novo coronary lesions requiring stenting: the ORBIT study
    Waksman, R
    Ajani, AE
    Cheneau, E
    Leborgne, L
    Stabile, E
    Pichard, AD
    Satler, LF
    Kent, KK
    EUROPEAN HEART JOURNAL, 2002, 23 : 141 - 141
  • [4] Oral rapamune to inhibit restenosis in patients with multi de-novo coronary lesions requiring stenting
    Waksman, R
    Ajani, AE
    Pichard, AD
    Pinnow, E
    Satler, LF
    Kent, KM
    Weissman, NJ
    Torguson, R
    Gambone, L
    Abbott, M
    Iloanya, P
    Lindsay, J
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 74A - 74A
  • [5] Oral rapamune to inhibit restenosis in patients with multi de novo coronary lesions requiring stenting: The ORBIT studies
    Waksman, R
    Ajann, A
    Torguson, R
    Pinnow, E
    Whitman, D
    Abbott, M
    Kuchulakanti, PK
    Bui, A
    Smith, K
    Pichard, A
    CIRCULATION, 2004, 110 (17) : 381 - 382
  • [6] Role of oral rapamycin to prevent restenosis in patients with de novo lesions undergoing coronary stenting:: results of the Argentina single centre study (ORAR trial)
    Rodríguez, AE
    Alemparte, MR
    Vigo, CF
    Pereira, CF
    Llauradóo, C
    Vetcher, D
    Pocovi, A
    Ambrose, J
    HEART, 2005, 91 (11) : 1433 - 1437
  • [7] Repeat percutaneous intervention for in-stent restenosis after sirolimus-eluting stent implantation in de novo coronary artery lesions
    Melzi, G.
    Cosgrave, J.
    Tsagalou, E.
    Airoldi, F.
    Michev, I.
    Montorfano, M.
    Sangiorgi, M. G.
    Colombo, A.
    EUROPEAN HEART JOURNAL, 2005, 26 : 416 - 416
  • [8] Angiographic restenosis after myocardial bridge stenting -: A comparative study with direct stenting of De-novo atherosclerotic lesions
    Kursaklioglu, H
    Barcin, C
    Iyisoy, A
    Kose, S
    Amasyali, B
    Isik, E
    JAPANESE HEART JOURNAL, 2004, 45 (04): : 581 - 589
  • [9] Spironolactone does not prevent restenosis after coronary stenting in humans
    Kursaklioglu, H
    Iyisoy, A
    Amasyali, B
    Celik, T
    Ozturk, C
    Kose, S
    Isik, E
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2004, 33 (06) : 769 - 774
  • [10] Comparison of the late restenosis rate between instent restenosis lesions and de novo lesions treated with Sirolimus Eluting stent
    Hosogi, S.
    EUROPEAN HEART JOURNAL, 2007, 28 : 396 - 397
12345